Delivery Order SPE2DR25D1109-SPE2DR26FFF5B
- Not listed
- The Defense Logistics Agency awarded a $351,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4-packs of 7.5 mcg/hr buprenorphine patches. Amerisourcebergen will deliver the transdermal patches to a location in Conshohocken, Pennsylvania by August 24, 2023 to support DLA's medical supply needs. As the prime contractor, Amerisourcebergen will likely fulfill the order through its corporate distribution division without involvement of major subcontractors. The delivery...
- The Defense Logistics Agency awarded a $32,430 delivery order to Amerisourcebergen Drug Corporation for buprenorphine 5 mcg/hr patches. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between July 5-6, 2023. Amerisourcebergen will provide 4 boxes of the buprenorphine patches to the DLA, the logistics agency of the Department of Defense, which manages worldwide supply chain operations for America's armed forces. No major subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,431 to Amerisourcebergen Drug Corporation for buprenorphine 7.5 mcg/hr patches. The order is for a quantity of four shipments to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 30, 2023. No additional details were provided on the original solicitation or whether this delivery order is placed against an existing...
- The Defense Logistics Agency Troop Support Medical awarded a $602,930 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4,561,624 units of 20 mcg/hr buprenorphine patches. The one-day contract has a period of performance from July 27 through July 28, 2023, with all work taking place in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for transdermal buprenorphine patches will support DLA's...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the delivery of Buprenorphine 20 mcg/hr Patch 4s, a specialty pharmaceutical product. The contract, valued at $1,060.77, has an ultimate completion date of April 21, 2023. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- The Defense Logistics Agency awarded a $972 firm fixed price delivery order to Amerisourcebergen Drug Corporation for buprenorphine 15 mcg/hr patches. The order is for a one-day period of performance to deliver the patches from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown Defense Logistics Agency location. No additional details were provided regarding the patches' intended use or association with any DLA programs. Amerisourcebergen will perform as the prime contractor...
- The Defense Logistics Agency Troop Support Medical awarded a $81,020 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the supply of 4562251502 Buprenorphine 15 mcg/hr patches. The contract has a period of performance of one day, from September 20 through September 21, 2023. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. No major subcontractors or set aside designations were indicated. This delivery order...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Buprenorphine 20 mcg/hr transdermal patches. The $2,056.78 contract has a completion date of July 29, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,119.40 firm fixed-price delivery order is for 4563118550 Buprenorphine 15 MCG/HR Patch 4S, a specialty medication. The award has an ultimate completion date of December 18, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at four hundred thirty dollars and ninety-five cents ($430.95) to Amerisourcebergen Drug Corporation for buprenorphine 15 mcg/hr patches. The order is for a quantity of four sets of the transdermal patches to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania and fulfills from August 16th through August 17th, 2023. No major subcontractors or set aside designations were...
- SPE2DR25D1109Indefinite Delivery Contract
- SPE2DR25D1109-SPE2DR26FFF5BDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,130.90 to AmerisourceBergen Drug Corp for Buprenorphine 20 mcg/hr patches (quantity of 4 units) on October 23, 2025, with an ultimate completion date of October 24, 2025. The award was made without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a child contract action under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The delivery order utilized firm fixed price pricing, reflecting the standardized nature of pharmaceutical procurement through the DLA supply chain. This delivery order represents a routine transaction within AmerisourceBergen Drug Corp's extensive portfolio of federal medical procurement activities. The company serves as a critical vendor for military and veteran healthcare systems, supplying a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. Buprenorphine patches are controlled substances commonly used for pain management in federal healthcare settings, including military medical facilities. The small transaction value and expedited completion timeline are typical for point-of-use pharmaceutical procurement conducted through the DLA's established prime vendor relationships, enabling rapid fulfillment of medical supply needs across the Defense Health System.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 10/23/25 |